HormoneLog

Why track perimenopause symptoms?

Updated September 6, 2026 · published by Baker Ventures LLC · sources cited inline

Because the appointment is short, the symptoms fluctuate, and memory is unreliable in a specific direction. Perimenopausal symptoms vary week to week. A consultation captures a snapshot, and what you recall in that snapshot is skewed toward the worst recent week and away from the pattern.

The strongest on-the-record support for writing it down is practical rather than clinical: The Menopause Society advises making a list of symptoms with their frequency and timing before a consultation. That is advice about preparation, and it is worth being precise that it is not the same as evidence that tracking improves outcomes.

Being equally precise about what is not true: NICE guideline NG23 does not recommend symptom diaries, scores or questionnaires. It covers diagnosis and management, including that diagnosis in women over 45 is made on symptoms without blood tests, and it sets out review cadence — but symptom tracking is not in it. Pages claiming "NICE recommends tracking" are wrong, and this site will not repeat that.

What a written record changes in the room

It replaces adjectives with frequency. "Bad sleep" is a sentence a clinician hears forty times a week. "Waking three times most nights for the last two months, worse in the week before a period" is information that can be acted on.

It makes a dose change legible. If you started a patch eight weeks ago, the useful question is what changed after it. That comparison requires a before, and the before has to have been recorded before you knew what would happen.

It stops the appointment being spent on reconstruction. A consultation is short. Spending the first half rebuilding the last three months from memory is expensive use of it.

It shows the pattern, not the peak. The week that made you book the appointment is by definition an outlier. A record shows whether it was.

What the evidence actually says about menopause apps

A systematic review — **Paripoorani, Gasteiger, Hawley-Hague & Dowding, BMC Women's Health 2023;23:518 — assessed 28 UK menopause apps and reported that none had been formally evaluated using validated menopause symptom scales, that most lacked any mechanism for sharing data with a healthcare provider or exporting structured records, that average readability sat at a college-graduate level, and that 32 percent indicated third-party data sharing.**

Two honest caveats, because this paper is widely miscited. It explicitly excluded symptom-tracking and paid apps, focusing on lifestyle and osteoporosis content. And the frequently-quoted figure "28 apps averaged 3.1 out of 5" does not appear in it. If you see that statistic attributed to this review, the citation is wrong.

What the review does establish is a real gap: apps in this space have generally not been built to produce something a clinician can use.

What tracking cannot do

It cannot diagnose anything. Not perimenopause, not anything else. Diagnosis is clinical judgement.

It cannot tell you your symptoms are severe. Published severity bands come from research populations, and displaying a number against them is an assessment. HormoneLog does not do it and this site does not do it.

It cannot substitute for a consultation. A record makes an appointment better. It does not replace one.

It cannot make a clinician listen. This is the honest limit, and the reason "bring a record" is sometimes offered as advice that quietly puts the burden on the patient. A structured record improves the odds. It is not a guarantee, and it is not your fault if it does not work.

What to record

WhatWhy it matters
Which symptomsVasomotor, psychological, somatic, urogenital — the clinical domains a clinician thinks in
How oftenFrequency is the number that carries information
How bad, on your own scaleConsistency with yourself over time is what makes it comparable
When it startedOnset and duration shape the clinical picture
What changes itTriggers and relief are actionable
What you have triedIncluding what did not work, and for how long
Treatment changes, with datesThe single most useful column if you are titrating HRT

Dates on treatment changes are the entry most people leave out and most need. How to log an HRT change.

On the licensed instruments

You will see the Greene Climacteric Scale and the Menopause Rating Scale referenced constantly in this space. Both are real, both are used in research, and both are licensed.

RWS Life Sciences administers the Greene Climacteric Scale and states it is available to academic researchers without fee while pharmaceutical companies pay per patient enrolled; there is no published fee tier covering a commercial consumer app. RWS also states the instrument cannot retain its official name if questions, responses or items are altered or removed, and that it was validated only for paper administration, with digital adaptations not validated. ZEG Berlin permits non-commercial use of the MRS without formal permission and requires contact for commercial licensing.

There is a genuine conflict in the record — the NIH-funded PhenX Toolkit publishes the GCS as protocol 880401 and states permission is not required. We are not going to resolve that by picking the answer we prefer.

What this means for HormoneLog: it does not implement either instrument, and the word validated is never used to describe this app. It describes published instruments only. What menopause symptom scales are and what a score can and cannot tell you.

This site is information, not medical advice. It is not a substitute for a consultation with a clinician, and nothing here diagnoses or treats any condition. Claims are linked to their sources so you can read them yourself.

Questions and answers

Does tracking menopause symptoms actually help?

The clearest on-the-record support comes from The Menopause Society, which advises making a list of symptoms with their frequency and timing before a consultation. That is guidance about preparing for an appointment rather than evidence that tracking improves outcomes, and the distinction matters.

Does NICE recommend keeping a symptom diary?

No. NICE guideline NG23 covers diagnosis and management of menopause, including that diagnosis in women over 45 can be made on symptoms without blood tests, and it sets out review cadence. It does not recommend symptom diaries, scores or questionnaires, and any page telling you it does is wrong.

What should I write down before a menopause appointment?

Which symptoms, how often, how severe on your own scale, when they started, what makes them better or worse, what you have already tried, and any treatment changes with dates. Concrete frequency beats adjectives - three night wakings most nights for two months is more useful than bad sleep.

How long should I track before an appointment?

Long enough to show a pattern rather than a bad week. Four to eight weeks is usually enough for a first appointment. If you are titrating HRT, tracking across a dose change is what makes the record informative, because the useful comparison is before against after.

Can an app diagnose perimenopause?

No. No app can diagnose perimenopause, and any app implying otherwise is making a claim it cannot support. Diagnosis is a clinical judgement, and NICE's position is that in women over 45 it is made on symptoms rather than blood tests.

Cite this pageHormoneLog. “Why track perimenopause symptoms?.” Baker Ventures LLC, September 6, 2026. https://hormonelog.bakerventuresstudio.com/why/why-track-perimenopause-symptoms/